Literature DB >> 1309438

Characterization of platelet-derived growth factor and platelet-derived growth factor receptor expression in asbestos-induced rat mesothelioma.

C Walker1, E Bermudez, W Stewart, J Bonner, C J Molloy, J Everitt.   

Abstract

Although altered expression of platelet-derived growth factor (PDGF) is a hallmark of human mesothelioma, expression of PDGF receptors has not been characterized in this cell type. In addition, the expression of this growth factor and its cognate receptor in rodent mesothelioma has not been investigated. In this study, examination of transformed mesothelial cells derived from asbestos-induced rat mesotheliomas revealed that these cells expressed high affinity PDGF receptors (Kd = 0.5 nM) and receptor number was 1.6 x 10(5)/cell. Western analysis using antibodies specific for either the alpha-type or beta-type PDGF receptor and Northern analysis using probes specific for alpha- and beta-type receptor RNA transcripts indicated that these cells expressed beta-type PDGF receptors but that alpha-type receptors could not be detected. However, when the mesothelioma-derived cells were examined for the expression of PDGF, no expression of this growth factor could be detected. The transformed cells expressed no detectable A- or B-chain PDGF RNA transcripts; and using a competitive enzyme immunoassay specific for isoforms containing the B chain of PDGF and a sandwich enzyme-linked immunosorbent assay specific for A-chain-containing isoforms, neither AA, nor AB, nor BB isoforms of this growth factor could be detected in medium conditioned by these cells. The absence of alterations in PDGF expression in rat mesothelioma, in contrast to the data for the human disease, suggests that the production of this growth factor by transformed mesothelial cells may be species specific.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1309438

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Nickel nanoparticles enhance platelet-derived growth factor-induced chemokine expression by mesothelial cells via prolonged mitogen-activated protein kinase activation.

Authors:  Ellen E Glista-Baker; Alexia J Taylor; Brian C Sayers; Elizabeth A Thompson; James C Bonner
Journal:  Am J Respir Cell Mol Biol       Date:  2012-06-14       Impact factor: 6.914

Review 2.  Malignant mesothelioma: new insights into tumour biology and immunology as a basis for new treatment approaches.

Authors:  J W Upham; M J Garlepp; A W Musk; B W Robinson
Journal:  Thorax       Date:  1995-08       Impact factor: 9.139

3.  Phase I Trial of Cediranib in Combination with Cisplatin and Pemetrexed in Chemonaive Patients with Unresectable Malignant Pleural Mesothelioma (SWOG S0905).

Authors:  Anne S Tsao; James Moon; Ignacio I Wistuba; Nicholas J Vogelzang; Gregory P Kalemkerian; Mary W Redman; David R Gandara; Karen Kelly
Journal:  J Thorac Oncol       Date:  2017-06-06       Impact factor: 15.609

Review 4.  Oncogenes and tumor-suppressor genes in mesothelioma--a synopsis.

Authors:  J F Lechner; J Tesfaigzi; B I Gerwin
Journal:  Environ Health Perspect       Date:  1997-09       Impact factor: 9.031

5.  Mesothelial cell proliferation after instillation of long or short asbestos fibers into mouse lung.

Authors:  I Y Adamson; J Bakowska; D H Bowden
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

6.  Inhaled carbon nanotubes reach the subpleural tissue in mice.

Authors:  Jessica P Ryman-Rasmussen; Mark F Cesta; Arnold R Brody; Jeanette K Shipley-Phillips; Jeffrey I Everitt; Earl W Tewksbury; Owen R Moss; Brian A Wong; Darol E Dodd; Melvin E Andersen; James C Bonner
Journal:  Nat Nanotechnol       Date:  2009-10-25       Impact factor: 39.213

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.